LC
GILD icon

Lawood & Co’s Gilead Sciences GILD Stock Holding History

Lawood & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$858K Sell
5,759
-25
-0.4% -$3.51K 0.59% 40
2026
Q2 		$731K Buy
5,784
+370
+7% +$48.8K 0.49% 44
2026
Q1 		$755K Buy
5,414
+260
+5% +$36.4K 0.7% 42
2025
Q4 		$633K Buy
+5,154
New +$626K 0.6% 46

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Lawood & Co's GILD Position: Q3 2026 in Review

Lawood & Co reduced its Gilead Sciences (GILD) stake by 0.43% in Q3 2026, selling an estimated $3.51K and leaving 5,759 shares worth $858K. The position accounts for 0.59% of the portfolio, ranked #40.

Lawood & Co first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Lawood & Co held 5,759 shares of Gilead Sciences worth $858K as of Q3 2026.
  • Lawood & Co sold 25 Gilead Sciences shares in Q3 2026, an estimated $3.51K.
  • Gilead Sciences made up 0.59% of Lawood & Co's portfolio in Q3 2026, its #40 holding.
  • Lawood & Co first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.